📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. (2014)

First Author: Pryce G

Attributed to: Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.13-239442

PubMed Identifier: 24121462

Publication URI: http://europepmc.org/abstract/MED/24121462

Type: Journal Article/Review

Volume: 28

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 1

ISSN: 0892-6638